drugset / Trial / NCT01828554

Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight

NCT01828554

Completed 8 enrolled University of Wisconsin, Madison
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this research study is to find what happens to capecitabine in the body when dosed using actual versus ideal body weight in subjects with advanced tumors and elevated body mass index.

Timeline

Start
2013-06
Primary completion
2018-04
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule 1250 mg/m2 Oral